GALECTIN-3 IS IMPLICATED IN THE PROGRESSION OF CASTRATION-RESISTANT PROSTATE CANCER THROUGH THE REGULATION OF ANGIOGENESIS AND ANDROGEN RECEPTOR SIGNALING

被引：0
|
作者：
Fukumori, Tomoharu
Daizumoto, Kei
Tsogt-Ochir, Dondoo
Yamamoto, Yasuyo
Yamaguchi, Kunihisa
Takahashi, Masayuki
Kanayama, Hiro-omi
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.2559
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP90-15
引用
收藏
页码：E1150 / E1150
页数：1
相关论文
共 50 条
  • [31] Progression of Castration-Resistant Prostate Cancer After Docetaxel and Androgen Receptor-Targeting Agent
    Gonzalez-Ochoa, Eduardo
    Verduzco-Aguirre, Haydee
    Crawford, E. David
    Bourlon, Maria T.
    ONCOLOGY-NEW YORK, 2020, 34 (04): : 125 - 129
  • [32] Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
    Zadra, Giorgia
    Ribeiro, Caroline F.
    Chetta, Paolo
    Ho, Yeung
    Cacciatore, Stefano
    Gao, Xueliang
    Syamala, Sudeepa
    Bango, Clyde
    Photopoulos, Cornelia
    Huang, Ying
    Tyekucheva, Svitlana
    Bastos, Debora C.
    Tchaicha, Jeremy
    Lawney, Brian
    Uo, Takuma
    D'Anello, Laura
    Csibi, Alfredo
    Kalekar, Radha
    Larimer, Benjamin
    Ellis, Leigh
    Butler, Lisa M.
    Morrissey, Colm
    McGovern, Karen
    Palombella, Vito J.
    Kutok, Jeffery L.
    Mahmood, Umar
    Bosari, Silvano
    Adams, Julian
    Peluso, Stephane
    Dehm, Scott M.
    Plymate, Stephen R.
    Loda, Massimo
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (02) : 631 - 640
  • [33] Developing small molecule inhibitors that target androgen receptor signaling in castration-resistant prostate cancer
    Chandrasekaran, Balaji
    Tyagi, Ashish
    Kolluru, Venkatesh
    Vadhanam, Aakash M.
    von Baby, Becca
    Gorle, Suresh
    Sirimulla, Suman
    Ramisetti, Srinivasa R.
    Sharma, Arun K.
    Ankem, Murali K.
    Damodaran, Chendil
    CANCER RESEARCH, 2019, 79 (13)
  • [34] PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer
    Zhang, Yulu
    Ming, Annan
    Wang, Junyan
    Chen, Wenmin
    Fang, Zhiqing
    PHARMACOLOGICAL RESEARCH, 2024, 205
  • [35] Treatment of Castration-Resistant Prostate Cancer: Updates on Therapeutics Targeting the Androgen Receptor Signaling Pathway
    Zhu, Wenhui
    Zhu, David S.
    Madan, Ravi A.
    Gulley, James L.
    Figg, William D.
    Dahut, William L.
    AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (02) : 176 - 181
  • [36] The kinesin KIF20A promotes progression to castration-resistant prostate cancer through autocrine activation of the androgen receptor
    Valeria A. Copello
    Kerry L. Burnstein
    Oncogene, 2022, 41 : 2824 - 2832
  • [37] Androgen biosynthesis in castration-resistant prostate cancer
    Penning, Trevor M.
    ENDOCRINE-RELATED CANCER, 2014, 21 (04) : T67 - T78
  • [38] The kinesin KIF20A promotes progression to castration-resistant prostate cancer through autocrine activation of the androgen receptor
    Copello, Valeria A.
    Burnstein, Kerry L.
    ONCOGENE, 2022, 41 (20) : 2824 - 2832
  • [39] Alternative polyadenylation of androgen receptor variants in castration-resistant prostate cancer
    Van Etten, Jamie L.
    Nyquist, Michael
    Li, Yingming
    LaRue, Rebecca
    Ho, Yeung
    Yang, Rendong
    Voytas, Daniel F.
    Henzler, Christine
    Dehm, Scott M.
    CANCER RESEARCH, 2018, 78 (13)
  • [40] Androgen Receptor Directed Therapies in Castration-Resistant Metastatic Prostate Cancer
    Won Kim
    Charles J Ryan
    Current Treatment Options in Oncology, 2012, 13 : 189 - 200
12345